Search

The place of BoNT in TMD: review article and case report

This article has been verified for CPD. Click the button below to answer a few short questions and download a form to be included in your CPD folder. Over the last decade, there has been a great deal of interest...

Recent developments in facelift surgery

Early facelifting procedures were documented in the 1900s, where skin undermining with excess skin excision along the hairline was performed. The 1970s witnessed a major change with an upsurge in public interest in facelift surgery, which led to innovative changes...

OPINION – Cosmetic surgery: a difficult reality with a simple solution

On 1 September 2022, an Independent Review released its long-awaited Report into Cosmetic Surgery in Australia [1]. Its key recommendation reflected the sentiment of our new, peer-reviewed, paper in the American Journal of Cosmetic Surgery entitled ‘Cosmetic Surgery Regulation in...

A short overview of the evolution of botulinum toxin type A formulations

Botulinum toxin type A (BoNT-A) is a potent neurotoxin produced by the bacterium Clostridium botulinum [1]. BoNT-A has been used for various therapeutic and aesthetic purposes, including the treatment of muscle disorders, chronic pain and facial wrinkles [2-4]. Over the...

Lipoedema awareness – the current state of play

Why do we need awareness? Around 40% of women in the UK are overweight or obese. Yet, within that 40% statistic, is a sub-set of women for whom that is not the full story. They suffer from a condition called...